Pharmaceutical companies lose bid to halt South Dakota law on discount drugs
Drug manufacturers wanted to limit number of pharmacies that hospitals can contract with in federal 340B program
A federal judge Monday refused to block the implementation of a new law that went into effect this year in South Dakota that provoked the ire of pharmaceutical companies, leading them to sue the state.
AbbVie, AstraZeneca and other pharmaceutical companies sued Attorney General Marty Jackley and Division of Insurance Director Larry Deiter to stop Senate Bill 154. The law placed restrictions on pharmaceutical companies from dictating which pharmacies some hospitals use to receive discounted drugs under a federal program.
The drug manufacturers asked the court for an injunction to stop the law. Judge Roberto Lange declined to grant the companies a preliminary injunction.
South Dakota fire departments replace PFAS foam with soy-based alternative
More South Dakota firefighting agencies are swapping out their fire suppressant inventories once widely used by emergency responders for alternatives derived closer to home.
